Scientists trace a new Drug's journey through the body
NCT ID NCT07364214
Summary
This early-stage study aims to understand how the body processes and eliminates the experimental drug quemliclustat. Eight healthy adult male volunteers will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will then measure how much of the drug and its byproducts appear in blood, urine, and feces to see how it leaves the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion
RECRUITINGLincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.